Back

Apoptotic and non-apoptotic circulating microparticles in patients with acute coronary syndromes

1 September 2019 (14:44 - 14:58)
Organised by:
Congress Presentation Part of: Non-troponin biomarkers in acute coronary syndromes Clinical ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Alexios Antonopoulos

Hippokration General Hospital, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom
Doctor K. Sopova (Mannheim, DE)
Abstract
Presentation thumbnail
Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction
Professor C. Garlichs (Flensburg, DE)
Abstract
Presentation thumbnail
HsCRP predicts mortality beyond troponin in 102,337 patients with suspected acute coronary syndrome (CRP-RISK study)
Doctor A. Kaura (London, GB)
Abstract Slides Video
Presentation thumbnail
Circulating levels of ST2 are associated with myocardial injury, left ventricular function and future adverse clinical events in patients with ST-elevation myocardial infarction.
Doctor J. Eritsland (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Non-troponin biomarkers in acute coronary syndromes

The Event

Event poster

ESC Congress 2019

1 September 2019 14:44 CET
You may be interested in
thumbnail
Congress Presentation
Endothelial-derived microparticles associated with adverse cardiac events and acute heart failure during hospitalization for acute myocardial infarction
29 June 2021
thumbnail
Congress Presentation
Acute coronary syndromes: men and women - same species, same disease, same manifestation?
15 March 2025
thumbnail
Congress Presentation
Circulating markers of autophagy dysfunction are associated with coronary artery disease in patients undergoing coronary angiography
1 September 2025
thumbnail
Congress Presentation
Plasma kinesis and prognostic impact of CRP in STEMI patients
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources